BRISTOL-MYERS SQUIBB COMPANY Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BRISTOL-MYERS SQUIBB COMPANY treasury stock, shares, acquired for the quarter ending 2018-03-31 was 2.60M shares.
- BRISTOL-MYERS SQUIBB COMPANY treasury stock, shares, acquired for the quarter ending 2017-09-30 was 3.80M shares.
- BRISTOL-MYERS SQUIBB COMPANY treasury stock, shares, acquired for the quarter ending 2013-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY treasury stock, shares, acquired for the quarter ending 2013-09-30 was 1.00M shares, a 96.77% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY treasury stock, shares, acquired for fiscal 2013 was 11.00M shares, a 84.93% decline from fiscal 2012.
- BRISTOL-MYERS SQUIBB COMPANY treasury stock, shares, acquired for fiscal 2012 was 73.00M shares, a 73.81% increase from fiscal 2011.
- BRISTOL-MYERS SQUIBB COMPANY treasury stock, shares, acquired for fiscal 2011 was 42.00M shares, a 82.61% increase from fiscal 2010.
- BRISTOL-MYERS SQUIBB COMPANY treasury stock, shares, acquired for fiscal 2010 was 23.00M shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2018-03-31 | 2.60M shares 10-Q · filed 2018-04-26 | |
| 2017-09-30 | 3.80M shares 10-Q · filed 2017-10-26 | |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | 11.00M shares 10-K · filed 2014-02-14 |
| 2013-09-30 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | 26.00M shares derived: sum of 4 quarters · filed 2014-04-29 |
| 2013-06-30 | 2.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | 56.00M shares derived: sum of 4 quarters · filed 2014-04-29 |
| 2013-03-31 | 8.00M shares 10-Q · filed 2014-04-29 | 71.00M shares derived: sum of 4 quarters · filed 2014-04-29 |
| 2012-12-31 | 15.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | 73.00M shares 10-K · filed 2014-02-14 |
| 2012-09-30 | 31.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | 70.00M shares derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | 17.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | 55.00M shares derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | 10.00M shares 10-Q · filed 2013-04-25 | 47.00M shares derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | 12.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | 42.00M shares 10-K · filed 2014-02-14 |
| 2011-09-30 | 16.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | 38.00M shares derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | 9.00M shares 10-Q · filed 2011-07-28 | 30.00M shares derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | 5.00M shares 10-Q · filed 2012-04-26 | 28.00M shares derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | 8.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | 23.00M shares 10-K · filed 2013-02-15 |
| 2010-09-30 | 8.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | |
| 2010-06-30 | 7.00M shares 10-Q · filed 2011-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |